User profiles for Kamal Patel
 | Kamal PatelNutrition PhD Candidate, Tufts University Verified email at jhsph.edu Cited by 8263 |
Systematic review: vitamin D and cardiometabolic outcomes
…, T Trikalinos, J Mitri, M Brendel, K Patel… - Annals of internal …, 2010 - acpjournals.org
Background: Vitamin D may modify risk for cardiometabolic outcomes (type 2 diabetes,
hypertension, or cardiovascular disease). Purpose: To examine the association between vitamin …
hypertension, or cardiovascular disease). Purpose: To examine the association between vitamin …
[HTML][HTML] Vitamin D and calcium: a systematic review of health outcomes.
Background Since the 1997 Dietary Reference Intake (DRI) values for vitamin D and calcium
were established new data have become available on their relationship, both individually …
were established new data have become available on their relationship, both individually …
[HTML][HTML] COVID-19 vaccine-induced antibody responses in immunosuppressed patients with inflammatory bowel disease (VIP): a multicentre, prospective, case …
…, R Linger, M Parkes, K Kok, KV Patel… - The lancet …, 2022 - thelancet.com
Background The effects that therapies for inflammatory bowel disease (IBD) have on immune
responses to SARS-CoV-2 vaccination are not yet fully known. Therefore, we sought to …
responses to SARS-CoV-2 vaccination are not yet fully known. Therefore, we sought to …
Self-measured blood pressure monitoring in the management of hypertension: a systematic review and meta-analysis
K Uhlig, K Patel, S Ip, GD Kitsios… - Annals of internal …, 2013 - acpjournals.org
Background: Clinical guidelines recommend that adults with hypertension self-monitor their
blood pressure (BP). Purpose: To summarize evidence about the effectiveness of self-…
blood pressure (BP). Purpose: To summarize evidence about the effectiveness of self-…
A systematic review of stakeholder engagement in comparative effectiveness and patient-centered outcomes research
OBJECTIVES We conducted a review of the peer-reviewed literature since 2003 to catalogue
reported methods of stakeholder engagement in comparative effectiveness research and …
reported methods of stakeholder engagement in comparative effectiveness research and …
Ustekinumab versus adalimumab for induction and maintenance therapy in biologic-naive patients with moderately to severely active Crohn's disease: a multicentre …
Background Active-comparator trials are important to inform patient and physician choice.
We aimed to evaluate the efficacy and safety of monotherapy with either ustekinumab or …
We aimed to evaluate the efficacy and safety of monotherapy with either ustekinumab or …
British Society of Gastroenterology guidance for management of inflammatory bowel disease during the COVID-19 pandemic
The COVID-19 pandemic is putting unprecedented pressures on healthcare systems globally.
Early insights have been made possible by rapid sharing of data from China and Italy. In …
Early insights have been made possible by rapid sharing of data from China and Italy. In …
[HTML][HTML] Fructose, high-fructose corn syrup, sucrose, and nonalcoholic fatty liver disease or indexes of liver health: a systematic review and meta-analysis
Background: Concerns have been raised about the concurrent temporal trend between
simple sugar intakes, especially of fructose or high-fructose corn syrup (HFCS), and rates of …
simple sugar intakes, especially of fructose or high-fructose corn syrup (HFCS), and rates of …
Anti-SARS-CoV-2 antibody responses are attenuated in patients with IBD treated with infliximab
…, DPB McGovern, SJ Mehta, CD Murray, KV Patel… - Gut, 2021 - gut.bmj.com
Objective Antitumour necrosis factor (anti-TNF) drugs impair protective immunity following
pneumococcal, influenza and viral hepatitis vaccination and increase the risk of serious …
pneumococcal, influenza and viral hepatitis vaccination and increase the risk of serious …
[HTML][HTML] COVID-19 vaccine-induced antibody and T-cell responses in immunosuppressed patients with inflammatory bowel disease after the third vaccine dose (VIP) …
…, R Linger, M Parkes, K Kok, KV Patel… - The Lancet …, 2022 - thelancet.com
Background COVID-19 vaccine-induced antibody responses are reduced in patients with
inflammatory bowel disease (IBD) taking anti-TNF or tofacitinib after two vaccine doses. We …
inflammatory bowel disease (IBD) taking anti-TNF or tofacitinib after two vaccine doses. We …